FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2338518322> ?p ?o ?g. }

• W2338518322 endingPage "28522" @default.
• W2338518322 startingPage "28510" @default.
• W2338518322 abstract "// Maria Carmela Cantisani 1 , Alessia Parascandolo 2 , Merja Perälä 3, 4 , Chiara Allocca 2 , Vidal Fey 3, 4 , Niko Sahlberg 3, 4 , Francesco Merolla 5 , Fulvio Basolo 6 , Mikko O. Laukkanen 1 , Olli Pekka Kallioniemi 7 , Massimo Santoro 2, 8 , Maria Domenica Castellone 8 1 IRCCS SDN, Naples, Italy 2 Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universita’ Federico II, Naples, Italy 3 Medical Biotechnology, VTT Technical Research Centre of Finland, Turku, Finland 4 Center for Biotechnology, University of Turku, Turku, Finland 5 Dipartimento di Scienze Biomediche Avanzate, Università Federico II, Naples, Italy 6 Division of Pathology, Department of Surgery, University of Pisa, Pisa, Italy 7 FIMM-Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland 8 Istituto di Endocrinologia ed Oncologia Sperimentale “G. Salvatore” (IEOS), C.N.R., Naples, Italy Correspondence to: Maria Domenica Castellone, e-mail: mcastell@unina.it Keywords: kinases, screening, siRNA, thyroid carcinoma Received: October 01, 2015      Accepted: March 02, 2016      Published: April 4, 2016 ABSTRACT RET, BRAF and other protein kinases have been identified as major molecular players in thyroid cancer. To identify novel kinases required for the viability of thyroid carcinoma cells, we performed a RNA interference screening in the RET/PTC1(CCDC6-RET)-positive papillary thyroid cancer cell line TPC1 using a library of synthetic small interfering RNAs (siRNAs) targeting the human kinome and related proteins. We identified 14 hits whose silencing was able to significantly reduce the viability and the proliferation of TPC1 cells; most of them were active also in BRAF-mutant BCPAP (papillary thyroid cancer) and 8505C (anaplastic thyroid cancer) and in RAS-mutant CAL62 (anaplastic thyroid cancer) cells. These included members of EPH receptor tyrosine kinase family as well as SRC and MAPK (mitogen activated protein kinases) families. Importantly, silencing of the identified hits did not affect significantly the viability of Nthy-ori 3-1 (hereafter referred to as NTHY) cells derived from normal thyroid tissue, suggesting cancer cell specificity. The identified proteins are worth exploring as potential novel druggable thyroid cancer targets." @default.
• W2338518322 created "2016-06-24" @default.
• W2338518322 creator A5010043477 @default.
• W2338518322 creator A5024903509 @default.
• W2338518322 creator A5028837841 @default.
• W2338518322 creator A5035771083 @default.
• W2338518322 creator A5048243012 @default.
• W2338518322 creator A5050670008 @default.
• W2338518322 creator A5051690707 @default.
• W2338518322 creator A5052914371 @default.
• W2338518322 creator A5060902293 @default.
• W2338518322 creator A5061495027 @default.
• W2338518322 creator A5063299710 @default.
• W2338518322 creator A5080374621 @default.
• W2338518322 date "2016-04-04" @default.
• W2338518322 modified "2023-10-17" @default.
• W2338518322 title "A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability" @default.
• W2338518322 cites W1553998446 @default.
• W2338518322 cites W1564408770 @default.
• W2338518322 cites W1594899067 @default.
• W2338518322 cites W1848939527 @default.
• W2338518322 cites W1961136802 @default.
• W2338518322 cites W1975253423 @default.
• W2338518322 cites W1980815930 @default.
• W2338518322 cites W1984185945 @default.
• W2338518322 cites W1987229132 @default.
• W2338518322 cites W1997670728 @default.
• W2338518322 cites W1999868376 @default.
• W2338518322 cites W2000000810 @default.
• W2338518322 cites W2003010548 @default.
• W2338518322 cites W2003780876 @default.
• W2338518322 cites W2008919192 @default.
• W2338518322 cites W2018981297 @default.
• W2338518322 cites W2020748099 @default.
• W2338518322 cites W2022676725 @default.
• W2338518322 cites W2027855079 @default.
• W2338518322 cites W2040569146 @default.
• W2338518322 cites W2050573392 @default.
• W2338518322 cites W2054572266 @default.
• W2338518322 cites W2056766497 @default.
• W2338518322 cites W2057566461 @default.
• W2338518322 cites W2061440500 @default.
• W2338518322 cites W2062464922 @default.
• W2338518322 cites W2062836415 @default.
• W2338518322 cites W2062871120 @default.
• W2338518322 cites W2069792474 @default.
• W2338518322 cites W2070535697 @default.
• W2338518322 cites W2073243872 @default.
• W2338518322 cites W2081242185 @default.
• W2338518322 cites W2083969794 @default.
• W2338518322 cites W2084646304 @default.
• W2338518322 cites W2090395004 @default.
• W2338518322 cites W2093519279 @default.
• W2338518322 cites W2106423189 @default.
• W2338518322 cites W2107712702 @default.
• W2338518322 cites W2113822839 @default.
• W2338518322 cites W2114625470 @default.
• W2338518322 cites W2117642694 @default.
• W2338518322 cites W2132228274 @default.
• W2338518322 cites W2137675009 @default.
• W2338518322 cites W2138852119 @default.
• W2338518322 cites W2142795623 @default.
• W2338518322 cites W2144665159 @default.
• W2338518322 cites W2145365512 @default.
• W2338518322 cites W2157219956 @default.
• W2338518322 cites W2159234812 @default.
• W2338518322 cites W2164353306 @default.
• W2338518322 cites W2168388892 @default.
• W2338518322 cites W2170776898 @default.
• W2338518322 cites W2287994291 @default.
• W2338518322 cites W4238271183 @default.
• W2338518322 cites W947525378 @default.
• W2338518322 doi "https://doi.org/10.18632/oncotarget.8577" @default.
• W2338518322 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5053742" @default.
• W2338518322 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27058903" @default.
• W2338518322 hasPublicationYear "2016" @default.
• W2338518322 type Work @default.
• W2338518322 sameAs 2338518322 @default.
• W2338518322 citedByCount "13" @default.
• W2338518322 countsByYear W23385183222016 @default.
• W2338518322 countsByYear W23385183222017 @default.
• W2338518322 countsByYear W23385183222019 @default.
• W2338518322 countsByYear W23385183222020 @default.
• W2338518322 countsByYear W23385183222021 @default.
• W2338518322 crossrefType "journal-article" @default.
• W2338518322 hasAuthorship W2338518322A5010043477 @default.
• W2338518322 hasAuthorship W2338518322A5024903509 @default.
• W2338518322 hasAuthorship W2338518322A5028837841 @default.
• W2338518322 hasAuthorship W2338518322A5035771083 @default.
• W2338518322 hasAuthorship W2338518322A5048243012 @default.
• W2338518322 hasAuthorship W2338518322A5050670008 @default.
• W2338518322 hasAuthorship W2338518322A5051690707 @default.
• W2338518322 hasAuthorship W2338518322A5052914371 @default.
• W2338518322 hasAuthorship W2338518322A5060902293 @default.
• W2338518322 hasAuthorship W2338518322A5061495027 @default.
• W2338518322 hasAuthorship W2338518322A5063299710 @default.
• W2338518322 hasAuthorship W2338518322A5080374621 @default.
• W2338518322 hasBestOaLocation W23385183221 @default.

• next